International Patent: DE NOVO DESIGNED PROTEINS TARGETING GLP1R, PAC1R, AND PTH1R

GENEVA, Oct. 1 -- NOVO NORDISK A/S filed a patent application (US2026/017387) for “DE NOVO DESIGNED PROTEINS TARGETING GLP1R, PAC1R, AND PTH1R”. With publication no. WO/2026/192792, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 14/605

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....